Description

2-Chloro-3-(3,5-Dimethyl-Pyrazol-1-Yl)-Quinoxaline is a high-value, heterocyclic organic compound that serves as a critical synthetic intermediate in advanced chemical research and development. Its unique molecular architecture, featuring fused quinoxaline and pyrazole rings, makes it a versatile building block for constructing complex molecules with targeted functionalities. This compound is primarily utilized by R&D chemists and process development scientists in the pharmaceutical and agrochemical industries for creating novel active ingredients and functional materials.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of novel drug candidates, particularly those targeting kinase inhibition and other biological pathways.
• Agrochemical Research: Building block for developing new generations of herbicides, fungicides, and insecticides with enhanced efficacy and selectivity.
• Material Science: Used in the research of organic electronic materials, such as organic light-emitting diodes (OLEDs) and semiconductors, due to its electron-deficient quinoxaline core.
• Chemical Biology: Serves as a scaffold for designing molecular probes and tool compounds to study biological processes and enzyme functions.
• Dye & Pigment Synthesis: Intermediate for creating specialized heterocyclic dyes and colorants with specific light-absorption properties.
• Academic & Contract Research: Essential reagent for universities and CROs (Contract Research Organizations) engaged in synthetic methodology and heterocyclic chemistry projects.

Basic Information

Product Name	2-Chloro-3-(3,5-Dimethyl-Pyrazol-1-Yl)-Quinoxaline
CAS No.	245039-37-6
Molecular Formula	C₁₃H₁₁ClN₄
Molecular Weight	258.70 g/mol
Synonyms	2-Chloro-3-(3,5-dimethyl-1H-pyrazol-1-yl)quinoxaline; Quinoxaline, 2-chloro-3-(3,5-dimethyl-1H-pyrazol-1-yl)-; 3-(3,5-Dimethylpyrazol-1-yl)-2-chloroquinoxaline; 2-Chloro-3-(3,5-dimethylpyrazol-1-yl)quinoxaline; 245039-37-6; CDPQ
EINECS	Contact for details

Quality Control

Our 2-Chloro-3-(3,5-Dimethyl-Pyrazol-1-Yl)-Quinoxaline is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical characterization, including HPLC, NMR, and mass spectrometry, to confirm identity and purity. Certificates of Analysis (COA) detailing all test results are provided with every shipment. We support cGMP (current Good Manufacturing Practice) standards for pharmaceutical applications and can tailor specifications to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 97.0% (Standard Grade)
Purity (HPLC)	≥ 98.0% / ≥ 99.0% (High Purity Grades Available)
Melting Point	Contact for details
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.